Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study

被引:35
|
作者
Gold, Michael S. [1 ]
Gidudu, Jane [2 ]
Erlewyn-Lajeunesse, Mich [3 ]
Law, Barbara [4 ]
机构
[1] Univ Adelaide, Discipline Paediat, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] Southampton Univ Hosp NHS Trust, Southampton, Hants, England
[4] Publ Hlth Agcy Canada, Sci Sect, Immunizat & Resp Infect Div, Ottawa, ON, Canada
关键词
Brighton Collaboration anaphylaxis case definition; Checklists; Immunization safety; Case study; SAFETY DATA; GUIDELINES; COLLECTION;
D O I
10.1016/j.vaccine.2010.04.041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Brighton Collaboration (BC) was established in 2000 with the aim of developing globally accepted standardized case definitions for adverse events following immunizations (AEFI) as well as guidelines for the collection, analysis and presentation of surveillance data. Some of the BC case definitions are complex and this may limit their application for use in post-marketing vaccine surveillance. Barriers to the application of the BC case definitions include an incomplete description of an adverse event and inconsistencies in reporter use of adverse event terms. We have taken the BC case definition for anaphylaxis and developed a clinical checklist and glossary of terms used in the case definition. It is anticipated that these resources can be used at a community level by AEFI reporters. If used, these resources could improve the quality of adverse event reports which would facilitate the application of the BC case definition at a regional and/or national level. (C) 2010 Published by Elsevier Ltd.
引用
收藏
页码:4487 / 4498
页数:12
相关论文
共 50 条
  • [1] The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)
    Bonhoeffer, J
    Kohl, K
    Chen, R
    Duclos, P
    Heijbel, H
    Heininger, U
    Jefferson, T
    Loupi, E
    VACCINE, 2002, 21 (3-4) : 298 - 302
  • [2] Standardized case definitions of adverse events following immunization (AEFI)
    Bonhoeffer, J
    Heininger, U
    Kohl, K
    Chen, RT
    Duclos, P
    Heijbel, H
    Jefferson, T
    Loupi, E
    VACCINE, 2004, 22 (5-6) : 547 - 550
  • [3] The Brighton Collaboration case definition for Bell's Palsy as an adverse event following immunization
    Rath, B. A.
    Cornblath, D. R.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2008, 13 (02) : 180 - 180
  • [4] Adverse Event Following Immunization (AEFI) in Children: An Analysis of Reporting in VigiAccess
    Pandey, Diksha
    Mehta, Geetika
    Sachdeva, Monika
    Tripathi, Rashmi
    DRUG RESEARCH, 2022, 72 (08) : 435 - 440
  • [5] Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization
    Kohl, Katrin S.
    Magnus, Manya
    Ball, Robert
    Halsey, Neal
    Shadomy, Sean
    Farley, Thomas A.
    VACCINE, 2008, 26 (50) : 6349 - 6360
  • [6] The development of standardized case definitions and guidelines for adverse events following immunization
    Kohl, Katrin S.
    Gidudu, Jane
    Bonhoeffer, Jan
    Braun, M. Miles
    Buettcher, Michael
    Chen, Robert T.
    Drammeh, Bakary
    Duclos, Philippe
    Heijbel, Harald
    Heininger, Ulrich
    Hummelman, Erik
    Jefferson, Thomas
    Keller-Stanislawski, Brigitte
    Loupi, Elisabeth
    Marcy, S. Michael
    VACCINE, 2007, 25 (31) : 5671 - 5674
  • [7] Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
    Liu, Yi-Chun Carol
    Ibekwe, Titus
    Kelso, John M.
    Klein, Nicola P.
    Shehu, Nathan
    Steuerwald, Wendy
    Aneja, Satinder
    Dudley, Matthew Z.
    Garry, Robert
    Munoz, Flor M.
    VACCINE, 2020, 38 (30) : 4717 - 4731
  • [8] Adverse events following immunization (AEFI) with COVID-19 vaccines: case series and literature review
    Millette, D.
    Balogun, M.
    Yip, V
    Chan, S. A.
    Lee, P.
    Gamal, N.
    Hashim, A.
    Phillips, D.
    Walsh, M.
    Trehan, P.
    Hanna-Bashara, L.
    Abdullah, A.
    Wernham, A.
    Tso, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (06) : E245 - E246
  • [9] Impact of nurse case manager - pharmacist collaboration on adverse-drug-event reporting
    Lata, PF
    Mainhardt, M
    Johnson, CA
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (05) : 483 - 487
  • [10] Factors Influencing Adverse Events Following Immunization (AEFI) of the COVID-19 vaccine: A Case Study in Ubon Ratchathani Province, Thailand
    Supapaan, Teeraporn Sadira
    Thongthai, Kittiyaporn
    Vinitchai, Pongdanai
    Praken, Wicharut
    Suwannakul, Suttasinee
    Poonphol, Prasittichai
    Donsamak, Sisira
    Boonlue, Tuanthon
    Kunawaradisai, Nonglek
    Dongtai, Wannisa
    Akanit, Uraiwan
    Watcharathanakij, Sawaeng
    Sripa, Saksit
    Kanjanawat, Patcharee
    Busapan, Jakkrit
    Pitchayajittipong, Chonladda
    Jinatongthai, Peerawat
    PHARMACY PRACTICE-GRANADA, 2024, 22 (04):